“Gefitinib: A Pharmacoeconomic Profile of Its Use in Patients With Non Small Cell Lung Cancer EGFR+”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 12, no. 2, June 2011, pp. 77-85, https://doi.org/10.7175/fe.v12i2.73.